(Q44718267)

5 December 2017

title

Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

5 December 2017

main subject

1 reference

1 reference

1 reference

Cenk Sayin N

1

1 reference

5 December 2017

Gücer F

2

1 reference

5 December 2017

Balkanli-Kaplan P

3

1 reference

5 December 2017

Ali Yüce M

4

1 reference

5 December 2017

Yardim T

5

1 reference

5 December 2017

publication date

1 October 2003

1 reference

Gynecological Endocrinology

5 December 2017

published in

1 reference

5 December 2017

volume

17

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

387-396

1 reference

Do hyperandrogenic women with normal menses have polycystic ovary syndrome?

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Polycystic ovary syndrome: a risk factor for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

The long term health consequences of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Prediction models for insulin resistance in the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Cardiovascular risk in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

The importance of diagnosing the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Polycystic ovaries--a common finding in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

8 Effects of sex steroids on serum lipids and lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Metabolic profiles and lipoprotein lipid concentrations in non-obese and obese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

Polycystic ovary syndrome is associated with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290278

10.1080/09513590312331290278

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference